Revenue Recognition and Collaborative Arrangements (Tables)

3 Months Ended

Mar. 31, 2020

Revenue Recognition and Collaborative Arrangements

Schedule of net revenue from collaborative arrangements

Net revenue recognized under our GSK Agreements was as follows:

	Three Months Ended March 31,
(In thousands)	2020		2019
Royalties from a related party - RELVAR/BREO	$	56,149	$	42,740
Royalties from a related party - ANORO		9,850		8,570
Royalties from a related party - TRELEGY		16,135		7,329
Total royalties from a related party		82,134		58,639
Less: amortization of capitalized fees paid to a related party		(3,456)		(3,456)
Royalty revenue from GSK	$	78,678	$	55,183